Skip to main content

Table 3 Maintenance dose weeks 1–4 (n = 64)

From: A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)

 

n (%)

Treated with Suboxone only throughout 4-week study period

53 (82.8)

Stayed at same dose of Suboxone only throughout 4-week study period

46 (71.9)

Dose reduction

4 (6.3)

Dose increase

1 (1.1)

Temporary dose change

2 (3.1)

Titrated1 with Subutex throughout 4-week study period

7 (11)

Discontinued treatment with Suboxone during 4-week study period

4 (6.2)

  1. 1patients had at the same time Suboxone and Subutex, first day 50:50 and during the first week gradually to Suboxone only